This Article Full Text Full Text (PDF) All Versions of this Article: 200301-104OCv1 169/5/578    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Erpenbeck, V. J. Articles by Hohlfeld, J. M. Search for Related Content PubMed PubMed Citation Articles by Erpenbeck, V. J. Articles by Hohlfeld, J. M.

Natural Porcine Surfactant Augments Airway Inflammation after Allergen Challenge in Patients with Asthma

Fraunhofer Institute of Toxicology and Experimental Medicine; Department of Respiratory Medicine, Hannover Medical School; and Department of Dermatology and Allergology, Hannover Medical School, Hannover, Germany

Correspondence and requests for reprints should be addressed to Jens M. Hohlfeld, M.D., Department of Respiratory Medicine, Hannover Medical School Carl-Neuberg-Strasse, 30625 Hannover, Germany. E-mail: hohlfeld.jens{at}mh-hannover.de

There is increasing evidence for a role of pulmonary surfactant in asthma and allergic inflammation. In murine asthma models, recent studies have demonstrated that surfactant components downregulate the allergic inflammation. Therefore, we tested the hypothesis that in individuals with mild asthma, a natural porcine surfactant preparation (Curosurf) given before segmental allergen challenge can reduce the allergic airway inflammation. Ten patients with asthma and five healthy control subjects were treated in two segments with either Curosurf or vehicle followed by local allergen challenge. Six additional patients with asthma received Curosurf before allergen challenge in one segment as above, but the second segment was instilled with Curosurf without allergen challenge. Unexpectedly, surfactant treatment augmented the eosinophilic inflammation 24 hours after allergen challenge. A direct chemotactic effect of Curosurf was excluded. However, levels of eotaxin and interleukin-5 were increased in bronchoalveolar lavage after Curosurf treatment, whereas IFN--levels and numbers of IFN-⁺ T cells were decreased. Curosurf had no influence on spreading and retention of allergen determined by allergen uptake in mice. These findings demonstrate that treatment with a natural porcine surfactant results in an augmentation of the eosinophilic inflammation after allergen challenge that is more likely due to immunomodulatory effects than to biophysical properties of the surfactant.

Key Words: asthma • allergy • immunomodulation • pulmonary surfactant • segmental allergen provocation

This article has been cited by other articles:

				F. Schaumann, M. Muller, A. Braun, B. Luettig, D. B. Peden, J. M. Hohlfeld, and N. Krug Endotoxin Augments Myeloid Dendritic Cell Influx into the Airways in Patients with Allergic Asthma Am. J. Respir. Crit. Care Med., June 15, 2008; 177(12): 1307 - 1313. [Abstract] [Full Text] [PDF]

				M. Kendall Fine airborne urban particles (PM2.5) sequester lung surfactant and amino acids from human lung lavage Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L1053 - L1058. [Abstract] [Full Text] [PDF]

				R. Koetzler, M. Saifeddine, Z. Yu, F.S. Schurch, M. D. Hollenberg, and F. H. Y. Green Surfactant as an Airway Smooth Muscle Relaxant Am. J. Respir. Cell Mol. Biol., May 1, 2006; 34(5): 609 - 615. [Abstract] [Full Text] [PDF]

				E. Agea, A. Russano, O. Bistoni, R. Mannucci, I. Nicoletti, L. Corazzi, A. D. Postle, G. De Libero, S. A. Porcelli, and F. Spinozzi Human CD1-restricted T cell recognition of lipids from pollens J. Exp. Med., July 18, 2005; 202(2): 295 - 308. [Abstract] [Full Text] [PDF]

				L. Fabbri, S. P. Peters, I. Pavord, S. E. Wenzel, S. C. Lazarus, W. MacNee, F. Lemaire, and E. Abraham Allergic Rhinitis, Asthma, Airway Biology, and Chronic Obstructive Pulmonary Disease in AJRCCM in 2004 Am. J. Respir. Crit. Care Med., April 1, 2005; 171(7): 686 - 698. [Full Text] [PDF]

				F. R. Moya, J. Gadzinowski, E. Bancalari, V. Salinas, B. Kopelman, A. Bancalari, M. K. Kornacka, T. A. Merritt, R. Segal, C. J. Schaber, et al. A Multicenter, Randomized, Masked, Comparison Trial of Lucinactant, Colfosceril Palmitate, and Beractant for the Prevention of Respiratory Distress Syndrome Among Very Preterm Infants Pediatrics, April 1, 2005; 115(4): 1018 - 1029. [Abstract] [Full Text] [PDF]

				F. Schaumann, P. J. A. Borm, A. Herbrich, J. Knoch, M. Pitz, R. P. F. Schins, B. Luettig, J. M. Hohlfeld, J. Heinrich, and N. Krug Metal-rich Ambient Particles (Particulate Matter2.5) Cause Airway Inflammation in Healthy Subjects Am. J. Respir. Crit. Care Med., October 15, 2004; 170(8): 898 - 903. [Abstract] [Full Text] [PDF]

				A. Baritussio Lung Surfactant, Asthma, and Allergens: A Story in Evolution Am. J. Respir. Crit. Care Med., March 1, 2004; 169(5): 550 - 551. [Full Text] [PDF]